Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W
Biomark Res. 2024; 12(1):96.
PMID: 39227970
PMC: 11373140.
DOI: 10.1186/s40364-024-00646-1.
Liu Y, Chen S, Wan X, Wang R, Luo H, Chang C
Cancer Commun (Lond). 2024; 44(11):1261-1286.
PMID: 39221971
PMC: 11570772.
DOI: 10.1002/cac2.12608.
Urs A, Goda C, Kulkarni R
Ann Transl Med. 2024; 12(4):63.
PMID: 39118939
PMC: 11304419.
DOI: 10.21037/atm-23-1824.
Guilatco A, Shah M, Weivoda M
J Bone Oncol. 2024; 47:100620.
PMID: 39072049
PMC: 11280103.
DOI: 10.1016/j.jbo.2024.100620.
Mendes M, Monteiro A, Neto E, Barrias C, Sobrinho-Simoes M, Duarte D
Int J Mol Sci. 2024; 25(8).
PMID: 38674015
PMC: 11050723.
DOI: 10.3390/ijms25084430.
Metabolic regulation of skeletal cell fate and function.
Stegen S, Carmeliet G
Nat Rev Endocrinol. 2024; 20(7):399-413.
PMID: 38499689
DOI: 10.1038/s41574-024-00969-x.
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling.
Tomasoni C, Arsuffi C, Donsante S, Corsi A, Riminucci M, Biondi A
Front Immunol. 2023; 14:1320497.
PMID: 38111584
PMC: 10725948.
DOI: 10.3389/fimmu.2023.1320497.
Orchiectomy sensitizes cortical bone in male mice to the harmful effects of kynurenine.
Bensreti H, Yu K, Alhamad D, Shaver J, Kaiser H, Zhong R
Bone. 2023; 173:116811.
PMID: 37244427
PMC: 10330684.
DOI: 10.1016/j.bone.2023.116811.
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies.
Tomasoni C, Pievani A, Rambaldi B, Biondi A, Serafini M
Hemasphere. 2023; 7(6):e896.
PMID: 37234820
PMC: 10208717.
DOI: 10.1097/HS9.0000000000000896.
Bone Marrow Adipose Tissue: Regulation of Osteoblastic Niche, Hematopoiesis and Hematological Malignancies.
Labella R, Vujacic M, Trivanovic D
Stem Cell Rev Rep. 2023; 19(5):1135-1151.
PMID: 36930385
DOI: 10.1007/s12015-023-10531-3.
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.
Zhang H, Liesveld J, Calvi L, Lipe B, Xing L, Becker M
Bone Res. 2023; 11(1):15.
PMID: 36918531
PMC: 10014945.
DOI: 10.1038/s41413-023-00249-w.
Metabolic crosstalk between stromal and malignant cells in the bone marrow niche.
Tirado H, Balasundaram N, Laaouimir L, Erdem A, van Gastel N
Bone Rep. 2023; 18:101669.
PMID: 36909665
PMC: 9996235.
DOI: 10.1016/j.bonr.2023.101669.
Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis.
Zazuli Z, Irham L, Adikusuma W, Sari N
Pharmaceuticals (Basel). 2022; 15(12).
PMID: 36559013
PMC: 9786277.
DOI: 10.3390/ph15121562.
Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias.
Zhai X, Jiang X
Biomedicines. 2022; 10(8).
PMID: 36009388
PMC: 9405586.
DOI: 10.3390/biomedicines10081841.
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
Stavrou V, Fultang L, Booth S, De Simone D, Bartnik A, Scarpa U
Cancer Immunol Immunother. 2022; 72(3):543-560.
PMID: 35962843
PMC: 9947083.
DOI: 10.1007/s00262-022-03268-4.
In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.
Salazar-Terreros M, Vernot J
Int J Mol Sci. 2022; 23(13).
PMID: 35806354
PMC: 9266537.
DOI: 10.3390/ijms23137350.